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Volumetric Remodeling of the
Proximal Left Coronary Artery:
Early Versus Late After Heart Transplantation
Klaus Pethig, MD, Bernd Heublein, MD, FACC, Rolf R. Meliss, MD, Axel Haverich, MD
Hannover, Germany
OBJECTIVES The aim of this study was to characterize progression of cardiac allograft vasculopathy (CAV)
with special respect to coronary artery geometry.
BACKGROUND As previously shown by intravascular ultrasound (IVUS), CAV is characterized by a
multifocal intimal hyperplasia. Little is known, however, about vascular remodeling processes
influencing vessel geometry and luminal narrowing.
METHODS In 30 heart transplant recipients serial IVUS studies were performed at baseline (BL) and
after a mean follow-up period of 12.5 6 2.5 months. Changes in plaque, lumen and vessel
volume were assessed in the proximal left anterior descending artery. Pattern of remodeling
was analyzed in patients “early” (n 5 15, BL study 1.4 6 0.7 months after heart
transplantation [HTX]) compared with “late” after HTX (n 5 15, BL 46.1 6 29.1 months).
RESULTS Plaque volume was found to increase by a mean of 23.8 6 25.9 mm3, not significantly
different within and beyond the 1st year after HTX. Significant differences, however, were
observed in changes in vessel volume with a mean decrease of 252.8 6 70.9 mm3 in the early
group, whereas late follow-up group presented with an enlargement of 32.3 6 46.0 mm3.
Based on these changes, lumen volume decreased by 273.2 6 69.8 mm3 early, in contrast to
a slight increase of 5.2 6 32.6 mm3 in the late group.
CONCLUSIONS Progression of CAV is a complex process, modified by changes in the vascular geometry.
Especially within the 1st year after HTX, luminal loss is influenced not only by an increase
in plaque area but by a decrease in total vessel volume as well. (J Am Coll Cardiol 1999;34:
197–203) © 1999 by the American College of Cardiology
Cardiac allograft vascular disease is characterized by a
multifocal myointimal hyperplasia, resulting in a continuous
luminal loss of coronary arteries within the graft (1–3). It
represents one of the most accelerated progressing coronary
syndromes in the human heart (4). Chronic inflammatory
reactions to immunologic and nonimmunologic injury are
considered to be involved in the pathogenesis (5). However,
beyond intimal hyperplasia, histopathologic examination
demonstrates inflammation in the media and adventitia of
coronary vessels as well (6,7). Development of adventitial
fibrosis can be regarded as part of this syndrome and raises
the question of influences on vascular geometry in terms of
coronary artery remodeling (8). To analyze these changes
under clinical conditions, in the form of longitudinal studies
within the vessel as well as studies of time-dependent
changes of matched sites, intravascular ultrasound (IVUS)
can be considered to be the imaging procedure of choice. All
major vascular structures, such as lumen, plaque and total
vessel area, can be visualized and analyzed quantitatively
(9,10).
Few studies are focused on questions of coronary artery
remodeling in heart transplant recipients as yet. They have
been able to demonstrate the presence of changes in vascular
geometry within the transplanted heart (11–13). As in
native coronary artery disease (14), not only plaque-induced
compensatory enlargement (positive remodeling) but vascu-
lar constriction (negative remodeling) could be shown to
influence luminal obstruction (12) as well. However, little is
known about the time course and contribution of remodel-
ing processes in progressive cardiac allograft vasculopathy.
Therefore, we analyzed serial intravascular ultrasound stud-
ies in a consecutive series of 30 patients. To exclude a
potential bias by analyzing not exactly identical sites, a
volumetric approach was chosen, as suggested in the past
(15), quantitating multiple images in a well defined region
of the proximal left anterior descending artery (LAD). The
aim of this study was 1) to analyze changes in plaque and
total vessel volume contributing to a luminal loss over time;
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and 2) to assess whether there are differences in changes of
vascular geometry early versus late after heart transplanta-
tion (HTX).
METHODS
Patients. After obtaining written informed consent, 30
consecutive heart transplant recipients underwent an IVUS
study of the LAD in addition to their routine surveillance
angiography. In 15 patients, baseline examination was
performed 1.4 6 0.7 months after transplantation (“early”
group); the other 15 were examined 46.1 6 29.1 months
after HTX (between 2 and 9 years, “late” group). Progres-
sion of disease was assessed in both groups by a follow-up
study at a mean interval of 12.6 6 1.7 months (early group)
and 12.4 6 3.1 months (late group).
There were 28 male and two female patients; mean age at
transplantation was 50.6 6 9.7 years. Immunosuppression
was performed by a triple therapy using cyclosporine,
azathioprine and prednisolone. Further demographic data
and transplant characteristics are detailed in Table 1.
Catherization procedure. Initially, all patients were eval-
uated by left heart catheterization including left ventricular
cineangiography as well as selective coronary arteriography
using a percutaneous transfemoral approach. Before intra-
vascular placement of a 0.014-in. (0.036 cm) coronary guide
wire (GWF-wire, Biotronik, Berlin, Germany), 10,000 IU
of heparin and 100 to 200 mg of intracoronary nitroglycerin
were administered into the left coronary artery to achieve
anticoagulation and optimal vasodilation, and to avoid
spasm. After placement of the IVUS catheter (monorail
3.5 F, 30 MHz, Sonicath, Boston Scientific, Natick, Mas-
sachusetts) under fluoroscopic guidance to the periphery of
the LAD (avoiding lumen diameters of less than 2.0 mm),
quality of IVUS images (Hewlett-Packard Sonos Intravas-
cular, Andover, Massachusetts) was optimized using stan-
dardized settings for the gain. During a subsequent pullback
maneuver (1 mm/s motorized device) images were docu-
mented on an SVHS videotape for further analysis.
Ultrasound image analysis and volumetric assessment by
planimetry. Image analysis was performed off-line from
the videotape. Frames were digitized and lumen, plaque as
well as vessel area were analyzed by planimetry with a
conventional image analysis system (Tape Measure, Indec
Systems, San Francisco, California). Lumen was defined as
the area within the intimal border, the total vessel as the
area within the media/adventitia boundary (characterized by
the external border of the echolucent zone) (10,16,17) and
plaque as the space between vessel and lumen area. As the
motorized pullback with a constant speed of 1 mm/s allows
for equidistant spacing of adjacent images, additional infor-
mation about longitudinal plaque distribution can be
achieved. Starting with the first complete vascular ring distal
to the bifurcation with the left circumflex artery, manual
planimetry was performed over a distance of 30 mm. Serial
cross-sectional images with the largest lumen area during
cardiac cycle were chosen every 2 mm toward the periphery
of the LAD (Fig. 1). Localization of small side branches or
other significant vascular markers were used to compare for
identity of vascular segments at baseline and follow-up
examination. Vascular sites with major side branches and
calcifications, occupying a vessel circumference of more than
30%, were excluded from quantification. Based on up to 16
cross-sectional measurements, plaque, lumen and total ves-
sel volume (in mm3) were calculated as follows: mean
cross-sectional area (in mm2) multiplied by the assessed
distance of 30 mm. A volume index was calculated as:
(plaque volume/vessel volume) 3 100.
Reproducibility of measurements. In a pilot study repro-
ducibility of volumetric assessment was analyzed in 10
patients. Two subsequent pullback maneuvers were per-
formed in identical vascular segments. A close correlation
between vessel, lumen and plaque volume (vessel: r 5 0.96;
Abbreviations and Acronyms
HTX 5 heart transplantation
IVUS 5 intravascular ultrasound
LAD 5 left anterior descending artery






(n 5 15) p 5
Age (yr) 50.6 6 9.7 53.0 6 9.5 48.6 6 9.8 0.22
Gender (male/female) 28/2 14/1 14/1 1.0
Donor age (yr) 36.7 6 10.2 34.9 6 11.2 38.5 6 9.0 0.34
Underlying disease (CAD/other) 13/17 6/9 7/8 0.71
Ischemia (min) 168.7 6 37.6 167.5 6 47.8 170.1 6 25.2 0.85
Time post HTX (mo) 23.7 6 30.4 1.4 6 0.7 46.1 6 29.1 , 0.001
Interval between studies (mo) 12.5 6 2.5 12.6 6 1.7 12.4 6 3.1 0.81
Demographic data of the study population, overall and differentiated for patients within versus beyond the 1st year after heart
transplantation (HTX). Except for time after transplantation, there were no significant differences between these subgroups.
CAD 5 coronary artery disease.
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lumen: r 5 0.99; plaque: r 5 0.99) could be shown,
demonstrating adequate reliability of measurements (Fig. 2).
Analysis of data. Statistical analysis was performed with
the SPSS (Cary, North Carolina) software package (version
6.1.3). Continuous data are presented as mean 6 1 standard
deviation. Univariate analysis to compare for different de-
mographic data between the early and late groups (Table 1)
was performed using the Student t test (for continuous data)
and the chi-square test (for noncontinuous data). Further on
the Student t test was used to test for progression of plaque
lumen as well as vessel volume and for differences between
the volumetric progression in early versus late follow-up. A
p value ,0.05 was considered to be statistically significant.
RESULTS
In total 910 vascular cross-sectional sites were analyzed
(mean 30.3 per patient).
Changes in plaque, lumen and vessel volume. Analyzing
the whole patient group, plaque volume increased from a
mean of 105.3 6 55.2 mm3 (range 31.8 to 240.0 mm3) at
baseline to 129.1 6 64.0 mm3 (range 30.6 to 259.2 mm3) at
follow-up examination by 23.8 6 25.9 mm3 or 22.6%
(p , 0.001). Total vessel volume could be shown to be
constant over time. From a mean of 450.9 6 96.9 mm3
(range 274.8 to 719.4 mm3) at baseline to 440.7 6
96.3 mm3 (range 300.0 to 723.6 mm3) at follow-up only a
small and not significant reduction in vessel volume was
observed (p 5 0.5). These changes resulted in a significant
decrease in lumen volume from 345.6 6 92.7 mm3 (range
203.1 to 566.1 mm3) to 311.6 6 84.9 mm3 (range 147.3 to
496.2 mm3) by 34.0 6 66.7 mm3 or 9.8% (p 5 0.009). For
details see Table 2.
Volumetric changes early versus late after transplanta-
tion. Increase in plaque volume did not differ significantly
in patients within versus beyond the first year after trans-
plantation (Table 3). However, changes in vessel lumen
presented to be strongly time dependent. A plot of the
individual changes (Fig. 3) demonstrates that the majority
of patients within the first year after transplantation expe-
rienced a decrease in vessel volume, whereas changes in the
late group are predominated by increasing volumes. These
differences in the early compared with the late group were
statistically highly significant (p 5 0.001, see Table 3).
Based on these findings, a large volume loss (increase in
plaque volume augmented by a decrease in vessel volume)
was observed in patients within the first year after trans-
plantation, contrasting with a slight lumen gain in the late
group. Therefore loss in vessel volume was the most
Figure 1. Graph demonstrating the procedure of volumetric quan-
tification of cardiac allograft vasculopathy. Based on a motorized
pullback, 16 equidistant cross-sectional sites were evaluated in the
proximal left anterior descending artery.
Figure 2. Reproducibility study for quantification of vessel (A) and
lumen (B) volume, demonstrating a close correlation between the
results of subsequent pullback maneuvers in the same vascular
region.
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important factor resulting in luminal narrowing in patients
early after heart transplantation (Fig. 4).
DISCUSSION
Our study shows that progression of allograft vascular
disease represents a complex process. Although plaque
volume was found to increase continuously over time, total
vessel volume decreased significantly within the first year
after heart transplantation as compared with a compensa-
tory enlargement in the late group of follow-up. The
resulting luminal loss, predominantly due to a negative
vascular remodeling, was maximal within the first year,
followed by a slight increase in lumen later on. To our
knowledge, these are the first volumetric observations of
vascular remodeling processes in heart transplant recipients
so far.
Coronary artery remodeling within the graft. Since the
first description of a compensatory vascular enlargement of
coronary arteries by Glagov in 1987 (18), vascular remod-
eling has become more recognized to be of major impor-
tance in influencing vessel geometry and luminal obstruc-
tion (19,20). However, as in native coronary artery disease,
not only compensatory enlargement but local vascular con-
striction was identified as a second pattern of remodeling
and identified to be present in heart transplant recipients as
well (12–14). Volumetric data in this study demonstrate
that in the overall study group about 30% of luminal loss is
due to a decrease in vessel volume; an increase in plaque
burden contributes to about 60% of lumen volume reduc-
tion. Differentiated over time, however, there are significant
differences in patients early (within the first year) versus late
(3.8 6 2.4 years) after heart transplantation. While in the
1st year a severe decrease in vessel volume (negative remod-
eling) contributes to more than 70% of luminal narrowing,
later on changes in vascular geometry are characterized by
an increase in vessel dimensions, even overcompensating the
increase in plaque burden (Fig. 5). Using this volumetric
approach, our data confirm previous observations in circum-
script stenosis (12), that an inadequate coronary artery
remodeling is an important mechanism in diffuse luminal
obstruction as well. The time-dependent differences, how-
ever, with an inadequate remodeling predominantly early
after HTX, are in contrast to findings by the Stanford group
(13). Focused on the temporal aspect of remodeling in heart
transplant recipients, Lim et al. (13) observed inadequate
vessel enlargement predominantly in patients late after
transplantation, whereas the early follow-up was character-
ized by a compensatory increase in vessel area. Although not
directly comparable (volumetric approach versus matched
pairs of single vascular sites), these discrepancies have to be
addressed in future studies focusing on these important
questions of coronary artery remodeling.
Pathophysiologic background. Currently, there is only
limited knowledge about pathophysiologic mechanisms un-
derlying coronary artery remodeling processes. An increase
in plaque-induced shear forces may represent a stimulus for
dilation of the vascular wall, resulting in compensatory
vessel enlargement as a general principle in atherosclerotic
disease (19,21). Especially patients beyond the first year
after HTX presented with this type of vascular adaptation.
The underlying mechanism of inadequate vascular remod-
eling, however, remains speculative. An inflammatory reac-
tion, as present in native coronary artery as well as in
allograft vascular disease (6,22), might be related to con-
strictive remodeling processes (8). Because transplanted
hearts present with the highest immunologic activity within
Table 2. Volumetric Progression—Overview
Change in
Overall <1 year >1 year
Baseline Follow-up Baseline Follow-up Baseline Follow-up
Plaque volume (mm3) 105.3 6 55.2 129.1 6 64.0 73.2 6 41.5 95.5 6 51.6 137.3 6 48.9 162.6 6 58.4
Lumen volume (mm3) 345.6 6 92.7 311.6 6 84.9 405.1 6 76.4 331.9 6 85.6 286.1 6 66.0 291.3 6 81.9
Vessel volume (mm3) 450.9 6 96.3 440.7 6 96.3 480.0 6 94.5 427.2 6 86.3 421.8 6 93.3 454.1 6 106.7
Volume index (%) 23.6 6 11.8 29.0 6 13.3 14.9 6 7.3 22.5 6 12.9 32.2 6 8.8 35.6 6 10.4
Absolute values for plaque, lumen and vessel volume as well as the volume index at baseline and at follow-up examination (overall and differentiated for patients “early” vs. “late”
after transplantation).






(n 5 15) p 5
Plaque volume (mm3) 23.8 6 25.9 22.3 6 29.8 25.3 6 22.2 0.8
Lumen volume (mm3) 234.0 6 66.7 273.2 6 69.8 5.2 6 32.6 0.001
Vessel volume (mm3) 210.3 6 72.9 252.8 6 70.9 32.3 6 46.0 0.001
Volume index (%) 5.5 6 6.8 7.5 6 8.9 3.4 6 2.9 0.1
Changes in plaque, lumen and vessel volume as well as in the volume index.
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the first year after transplantation (23), antigen-dependent
immunologic injury can be considered to be one of the most
important inflammatory stimuli, resulting in endothelial
dysfunction (24) as well as structural changes in vascular
geometry predominantly early after transplantation (8).
Implications for diagnostic approaches. Regardless of the
pathophysiologic background, these observations should
have considerable impact on future diagnostic approaches.
Using quantitative angiography, a progressive luminal nar-
rowing in graft coronary arteries has been known for several
years (25,26). However, data on vascular remodeling dem-
onstrate that an increase in plaque mass represents only one
aspect of disease. Regarding luminal obstruction, a decrease
in vessel area or vascular volume, respectively, might be of
even greater importance, especially within the first year after
transplantation. To define the natural course of disease, and
to form a basis for future prognostic interpretations as well
as a follow-up after preventive or therapeutic interventions,
remodeling processes have to be taken into consideration.
Beneath differentiated changes in plaque, lumen and vessel
volume, the use of a volume index as a derived measure of
plaque and vessel volume might be helpful and more
representative than plaque volume alone.
Implications on therapy. Observations about vascular re-
modeling over the last years supports the increasing evi-
dence that cardiac allograft vasculopathy is a process not
limited to the intima of coronary arteries. Beyond therapeu-
tical approaches focusing on intimal hyperplasia (like cal-
cium antagonists or lipid-lowering drugs [27–29]) an anti-
inflammatory therapy addressing all vascular structures
might be more successful in prevention of disease. Espe-
cially in the early period after transplantation an intensified
immunosuppressive therapy or antagonists against proin-
flammatory cytokines (30) should be discussed as a perspec-
tive for the future.
Limitations. Data for this study were obtained from a
limited vascular region only. The proximal LAD was chosen
because of the usually linear vessel course of the proximal
left coronary artery with a low rate of artifacts. Although
volume calculations (based on a formula for a straight tube)
can only give an estimate of the “true” vascular geometry,
not absolute numbers but changes in vessel, lumen and
plaque volume are analyzed under the aspect of vascular
remodeling. Demonstrating the good reproducibility of
measurements at each time point (Fig. 2), this procedure
might be the most appropriate method available today.
These data represent first observations on volumetric
remodeling; they do not claim to be representative for the
entire coronary vascular bed. Especially peripheral vascular
structures and intramuscular coronary arteries might have a
completely different pattern of intimal hyperplasia and
vascular remodeling (31).
Although IVUS can be regarded as the most sensitive
imaging procedure, an in vivo study cannot differentiate
functional changes (in terms of a primary endothelial
dysfunction resulting in inadequate dilation) from struc-
tural processes (in terms of changes of the extracellular
matrix or fibrosing processes in the adventitia). Princi-
pally, histopathologic observations demonstrate the pres-
ence of growth factors (7) as well as severe perivascular
fibrosis in transplanted hearts (8), suggesting inadequate
remodeling to be caused by structural changes in the
whole vessel.
Finally the question of the heterogeneous patient popu-
lation should be addressed. Especially patients in the late
group were followed at different time points after HTX.
Figure 3. Individual changes in total vessel area in patients “early”
(A) versus “late” (B) after heart transplantation.
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Further studies in larger patient cohorts are required to
clarify the time dependency of remodeling processes after
HTX.
Conclusions. Volumetric progression of cardiac allograft
vasculopathy represents a complex process. Beyond intimal
hyperplasia, remodeling processes are of major importance
in influencing vascular geometry and luminal obstruction.
Especially within the first year after HTX, luminal loss is
influenced not only by an increase in plaque area but to a
large extend by a decrease in total vessel volume, whereas
changes later on are characterized predominantly by a
vascular enlargement.
Reprint requests and correspondence: Klaus Pethig, MD, De-
partment of Thoracic and Cardiovascular Surgery, Division of
Surgery, Hannover Medical School, D-30623 Hannover, Ger-
many. E-mail: Klaus.Pethig@t-online.de.
Figure 4. Cross-sectional examples of identical vascular sites in the left anterior descending artery 3.5 and 4.5 years after heart
transplantation. Note compensatory enlargement of vascular cross-sectional area (characterized by the echolucent zone of the lamina
elastica externa) maintaining a constant vessel lumen despite an increase in plaque mass.
Figure 5. Bar graph demonstrating the significant decrease in mean vessel area, which is the most
important factor responsible for the considerable luminal loss “early” after transplantation. In contrast
changes “late” after heart transplantation are shown to be characterized by a mean increase in vessel
volume, resulting in a slight increase in lumen volume. White bars 5 plaque volume; black bars 5 lumen
volume; shaded bars 5 vessel volume. ppp , 0.001.
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